Prognostic Value of Baseline and Change of Soluble Suppression of Tumorigenicity-2 in Light Chain Cardiac Amyloidosis

被引：0
|
作者：
Xin, Anran
Li, Xinqing
Huang, Yan
Zhuang, Xiaofeng
Zhao, Xuemei
Wang, Jinxi
Zhou, Ping
Zhang, Jian
Zhang, Yuhui
机构：
来源：
CIRCULATION | 2024年 / 150卷
关键词：
D O I：
10.1161/circ.150.suppl_1.4142598
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4142598
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Soluble suppression of tumorigenicity-2 in cardiac amyloidosis, hypertrophic and dilated cardiomyopathy
    Castiglione, V.
    Ghionzoli, N.
    Aimo, A.
    Teresi, L.
    Prontera, C.
    Masotti, S.
    Grigoratos, C.
    Genovesi, D.
    Barison, A.
    Todiere, G.
    Aquaro, G. D.
    Passino, C.
    Emdin, M.
    Vergaro, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 498 - 498
  • [2] Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure
    Huang, Dong-Hui
    Sun, Hao
    Shi, Jing-Pu
    CHINESE MEDICAL JOURNAL, 2016, 129 (05) : 570 - 577
  • [3] Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure
    Huang Dong-Hui
    Sun Hao
    Shi Jing-Pu
    中华医学杂志英文版, 2016, 129 (05) : 570 - 577
  • [4] Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure A Meta-Analysis
    Aimo, Alberto
    Vergaro, Giuseppe
    Passino, Claudio
    Ripoli, Andrea
    Ky, Bonnie
    Miller, Wayne L.
    Bayes-Genis, Antoni
    Anand, Inder
    Januzzi, James L.
    Emdin, Michele
    JACC-HEART FAILURE, 2017, 5 (04) : 280 - 286
  • [5] Prognostic and Diagnostic Value of Plasma Soluble Suppression of Tumorigenicity-2 Concentrations in Acute Respiratory Distress Syndrome
    Bajwa, Ednan K.
    Volk, Jessica A.
    Christiani, David C.
    Harris, R. Scott
    Matthay, Michael A.
    Thompson, B. Taylor
    Januzzi, James L.
    CRITICAL CARE MEDICINE, 2013, 41 (11) : 2521 - 2531
  • [6] Soluble Suppression of Tumorigenicity-2 as a Candidate Prognostic Marker for Stroke A Systematic Review
    Ahmadzadeh, Koohyar
    Dizaji, Shayan Roshdi
    Balabandian, Mohammad
    Ramawad, Hamzah Adel
    Yousefifard, Mahmoud
    ANNALS OF LABORATORY MEDICINE, 2023, 43 (06) : 585 - 595
  • [7] Prognostic Value of β1 Adrenergic Receptor Autoantibody and Soluble Suppression of Tumorigenicity-2 in Patients With Acutely Decompensated Heart Failure
    Sun, Yanxiang
    Feng, Li
    Hu, Bing
    Dong, Jianting
    Zhang, Liting
    Huang, Xuansheng
    Yuan, Yong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [8] Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure
    Gul, Ibrahim
    Yucel, Oguzhan
    Zararsiz, Abdullah
    Demirpence, Ozlem
    Yucel, Hasan
    Zorlu, Ali
    Yilmaz, Mehmet Birhan
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2017, 18 (03): : 200 - 205
  • [9] Serum Cardiac Biomarkers in Asymptomatic Hemodialysis Patients: Role of Soluble Suppression of Tumorigenicity-2
    Mancianti, Nicoletta
    Maresca, Barbara
    Palladino, Marco
    Salerno, Gerardo
    Cardelli, Patrizia
    Mene, Paolo
    Barberi, Simona
    BLOOD PURIFICATION, 2022, 51 (02) : 155 - 162
  • [10] Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure
    Oncel, Can Ramazan
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2018, 19 (03): : 228 - 228
12345